Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan P van Meerbeeck

Showing results (31-40 of 190) with videos related to

Pageof 19
Sort By:
Journal of Advanced Research|August 11, 2015
Mesothelioma treatment: Are we on target? A reviewBirgitta I Hiddinga, Christian Rolfo, Jan P van Meerbeeck
Current Opinion in Oncology|February 25, 2010
Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancerSofie De Craene, Veerle Surmont, Jan P van Meerbeeck
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 23, 2010
The emerging role for combined endosonography with fine needle aspiration in lung cancer staging: is the scope the right one?Kurt G Tournoy, Jan P van Meerbeeck, Frank Vermassen
Expert Review of Anticancer Therapy|February 19, 2008
What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?Jan P Van Meerbeeck, Rebecca De Pauw, Kurt Tournoy
Translational Lung Cancer Research|March 10, 2023
Surgical series in mesothelioma: navigating between biasesJo Raskin, Paul E Van Schil, Jan P Van Meerbeeck
Expert Review of Anticancer Therapy|June 17, 2014
Novel treatment options in stage I non-small-cell lung cancerSvitlana Tarasevych, Patrick Lauwers, Frederik Vandaele, et al.
Lung Cancer (Amsterdam, Netherlands)|August 6, 2016
O<sup>6</sup>-Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?Birgitta I Hiddinga, Patrick Pauwels, Annelies Janssens, et al.
The European Respiratory Journal|May 26, 2018
Aminopeptidase antibodies in mesothelioma: new wine deserves new sacksJan P van Meerbeeck, Gerrit Jansen, Elisa Giovannetti, et al.
Current Opinion in Pulmonary Medicine|May 26, 2009
What is the role for surgery in patients with stage III non-small cell lung cancer?Elke Vandenbroucke, Frederic De Ryck, Veerle Surmont, et al.
Acta Clinica Belgica|January 15, 2020
Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS dataBenoît Colinet, Jan P Van Meerbeeck, Tine Cuppens, et al.
Pageof 19

Showing results (31-40 of 190) with videos related to

Sort By:
Pageof 19
Journal of Advanced Research|August 11, 2015
Mesothelioma treatment: Are we on target? A reviewBirgitta I Hiddinga, Christian Rolfo, Jan P van Meerbeeck
Current Opinion in Oncology|February 25, 2010
Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancerSofie De Craene, Veerle Surmont, Jan P van Meerbeeck
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 23, 2010
The emerging role for combined endosonography with fine needle aspiration in lung cancer staging: is the scope the right one?Kurt G Tournoy, Jan P van Meerbeeck, Frank Vermassen
Expert Review of Anticancer Therapy|February 19, 2008
What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?Jan P Van Meerbeeck, Rebecca De Pauw, Kurt Tournoy
Translational Lung Cancer Research|March 10, 2023
Surgical series in mesothelioma: navigating between biasesJo Raskin, Paul E Van Schil, Jan P Van Meerbeeck
Expert Review of Anticancer Therapy|June 17, 2014
Novel treatment options in stage I non-small-cell lung cancerSvitlana Tarasevych, Patrick Lauwers, Frederik Vandaele, et al.
Lung Cancer (Amsterdam, Netherlands)|August 6, 2016
O<sup>6</sup>-Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?Birgitta I Hiddinga, Patrick Pauwels, Annelies Janssens, et al.
The European Respiratory Journal|May 26, 2018
Aminopeptidase antibodies in mesothelioma: new wine deserves new sacksJan P van Meerbeeck, Gerrit Jansen, Elisa Giovannetti, et al.
Current Opinion in Pulmonary Medicine|May 26, 2009
What is the role for surgery in patients with stage III non-small cell lung cancer?Elke Vandenbroucke, Frederic De Ryck, Veerle Surmont, et al.
Acta Clinica Belgica|January 15, 2020
Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS dataBenoît Colinet, Jan P Van Meerbeeck, Tine Cuppens, et al.
Pageof 19